Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BIT:AU

0.1250 AUD 0.00000.00%

As of 00:44:07 ET on 05/25/2015.

Snapshot for Biotron Ltd (BIT)

Open: 0.1250 Day's Range: 0.1200 - 0.1250 Volume: 59,203
Previous Close: 0.1250 52wk Range: 0.0836 - 0.1832 1-Yr Rtn: +49.51%

Stock Chart for BIT

No chart data available.
  • BIT:AU 0.1250
  • 1D
  • 1M
  • 1Y
0.1250
Interactive BIT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIT

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0109
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 34.88
Shares Outstanding (M) 279.04
30 Day Average Volume 573,310
Price/Book (mrq) 9.9499
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIT

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for BIT

Biotron Limited specializes in the funding, management and commercialization of biomedical projects that result from research conducted at the John Curtin School of Medical Research, a research institute within the Australian National University. The Group conducts diagnostic and therapeutic research with the intention of creating compounds and diagnostics that can be sold or licensed.

Michelle MillerManaging DirectorPeter James NightingaleSecretary
More Company Profile & Key Executives for BIT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil